Perspectives on the recommendations for skin cancer management during the COVID-19 pandemic

Affiliations

¹ Department of Dermatology, Columbia University Irving Medical Center, New York, New York. Electronic address: ljg2145@cumc.columbia.edu.
² Department of Dermatology, Columbia University Irving Medical Center, New York, New York.
³ Department of Dermatology, Stanford Medicine, Stanford, California.
⁴ Division of Hematology, Department of Medicine, Columbia University Irving Medical Center, New York, New York.
⁵ Department of Dermatology, University of Washington Medical Center, Seattle, Washington.
⁶ Department of Surgery, Columbia University Irving Medical Center, New York, New York.
⁷ Department of Dermatology, University of Arizona College of Medicine, Phoenix, Arizona.

Larisa J Geskin et al. J Am Acad Dermatol. 2020 Jul.

. 2020 Jul;83(1):295-296.

doi: 10.1016/j.jaad.2020.05.002. Epub 2020 May 6.

¹ Department of Dermatology, Columbia University Irving Medical Center, New York, New York. Electronic address: ljg2145@cumc.columbia.edu.
² Department of Dermatology, Columbia University Irving Medical Center, New York, New York.
³ Department of Dermatology, Stanford Medicine, Stanford, California.
⁴ Division of Hematology, Department of Medicine, Columbia University Irving Medical Center, New York, New York.
⁵ Department of Dermatology, University of Washington Medical Center, Seattle, Washington.
⁶ Department of Surgery, Columbia University Irving Medical Center, New York, New York.
⁷ Department of Dermatology, University of Arizona College of Medicine, Phoenix, Arizona.

No abstract available

Comment in

Struggling with COVID: Every cancer patient is unique and needs their own plan.
Alam M. Alam M. J Am Acad Dermatol. 2020 Jul;83(1):297-298. doi: 10.1016/j.jaad.2020.04.166. Epub 2020 May 6. J Am Acad Dermatol. 2020. PMID: 32387664 Free PMC article. No abstract available.

1. Ueda M., Martins R., Hendrie P.C., et al. Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal. J Natl Compr Canc Netw. 2020;18(4):366–369. - PubMed
1. Baum C.L., Wright A.C., Martinez J.-C., et al. A new evidence-based risk stratification system for cutaneous squamous cell carcinoma into low, intermediate, and high risk groups with implications for management. J Am Acad Dermatol. 2018;78:141–147. - PubMed